Phage Based Diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us
Menu
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us

Johne’s Disease

Actiphage is the world’s first test for Johne's Disease that can detect live mycobacteria in the blood of calves and young animals. It provide results within days enabling effective disease management

Loading...

One in three UK herds include carriers of Johne’s Disease, also known as MAP, a chronic wasting disease with no treatment and no compensation, that can lie undetected until animals are over three years old.

Actiphage by detecting live mycobacteria enables disease management through the removal of these animals from the herd or prior to movement. 

Johne's disease lies dormant in herd

Johne's Disease is transmitted to the calf, although older animals can be infected by the faecal oral route, so the risk comes from contaminated calfing areas and sharing milk to feed calves. It can remain dormant in the animal until it is triggered by stress or an other infection.

The disease can have a serious economic impact through

  • Reduced milk yields and poor fertility
  • Loss of body condition
  • Increasing vulnerability to mastitis
  • Risk of contaminated milk

A pre-breeding test would be good way to help control Johne's. Preventing positive animals from being bred would reduce the spread of bacteria in calving areas and prevent the infection of calves through milk.

Detect carriers before they spread disease

Actiphage detects live mycobacteria in blood or milk samples, unlike the antibody test, which measures the immune response to the disease. This means it can identify animals with Johne's Disease before they become infectious and start to shed the bacteria.

So, for the first time Actiphage enables farmers to introduce a disease management strategy to eradicate Johne’s Disease:

  • Pre-breeding test - test the cows before breeding so infected animals are prevented from breeding
  • Pre-movement test - a blood test of new stock will identify infected animals before you introduce them into your herd
  • Early identification - Actiphage can detect low numbers of mycobacteria in the blood of calves from 6 weeks1 and young animals. Enabling infected animals to be removed from the herd before they infect others
  • Prevent transmission - identifying and isolating animals with the disease before they shed in faeces will reduce the risk to adult animals.
  • Herd screening - the bulk milk test can provide an early indication of a problem in the herd, or provide confidence that milk is free of MAP.
  • DIVA test - a vaccine is available for Johne’s which reduces clinical disease but will not prevent transmission. Unlike the current test, Actiphage can distinguish between live infection and vaccinated animals.

Testing service for blood and milk

Actiphage is a simple test for blood or bulk milk that can be used to screen the herd to detect infected animals. It enables management of the herd to reduce the economic loss and to provide quality assurance to retail customers and consumers.

For the first time Actiphage enables farmers to introduce a strategy to remove Johne's Disease/MAP from the herd.

  • Avoid introducing infected animals into your herd
  • Manage carriers before they shed the disease and infect others
  • Prevent infected animals from calving
  • Test bulk milk for quality assurance

If you would like more information about Actiphage do get in contact. (note the commercial Johne's Disease Testing service was suspended in January 2023 but work continues with research partners.)

  1. Pelletier C. et al, 'Detection of active infection of new-born calves by Mycobacterium avium subsp. paratuberculosis (MAP) in first days of life', Abstract presented at the European Association of Veterinary Laboratory Diagnosticians Congress (2018)

Suspending Johne’s Disease testing service from Jan 2023

PBD Biotech has announced that is focusing its efforts on developing Actiphage as a rapid blood test for Human Tuberculosis (TB) and will be suspending its commercial Johne’s Testing Service (from January 2023) More information.

Please contact us if you would like to discuss this further.

 

Related content

Loading...
See PBD Biotech at The Dairy Show

5 October 2022

See us at The Dairy Show

September 6, 2022
Ensuring consumer confidence in dairy products has never been more vital and we are delighted to have the opportunity to talk about our new blood test and bulk milk test with producers, cheesemakers, dairy companies and others across the industry...
See PBD Biotech at The Dairy Show

5 October 2022

See us at The Dairy Show

September 6, 2022
Ensuring consumer confidence in dairy products has never been more vital and we are delighted to have the opportunity to...

Actiphage detects Johne’s disease in vaccinated goat

June 9, 2022
A study presented at ICP 2022 has shown that the blood test Actiphage is able to distinguish between goats that are naturally infected and those vaccinated against Mycobacterium avium subspecies paratuberculosis (MAP), the pathogen that causes Johne’s Disease, supporting the...

Actiphage detects Johne’s disease in vaccinated goat

June 9, 2022
A study presented at ICP 2022 has shown that the blood test Actiphage is able to distinguish between goats that...
bison MAP diagnostic

Actiphage identifies strain of mycobacteria in blood of bison

May 26, 2022
Results presented at ICP (12-16th June) from first study in North American bison, shows capacity of Actiphage to sub-type mycobacteria in blood.
bison MAP diagnostic

Actiphage identifies strain of mycobacteria in blood of bison

May 26, 2022
Results presented at ICP (12-16th June) from first study in North American bison, shows capacity of Actiphage to sub-type mycobacteria...
cow

Why breakthrough human trials of Actiphage are good news for farmers

May 12, 2022
The findings are a real breakthrough for animal diagnosis as it provides clinical evidence that detection of low levels of mycobacteria in the blood is an indication that the animal is infected and has the potential to develop disease.
cow

Why breakthrough human trials of Actiphage are good news for farmers

May 12, 2022
The findings are a real breakthrough for animal diagnosis as it provides clinical evidence that detection of low levels of...
1 2 3 Next »

developers of phage-based diagnostics

Contact Us

Registered Company Address
Grosvenor St Paul’s
Grosvenor House
11 St Paul’s Square
Birmingham
B3 1RB
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house

  • Follow Us!
PBD Biotech

More reasons to invest in better diagnostics for #tuberculosis 1.6 million preventable deaths and increased pressure on the few treatments available. #EndTB

Read More
PBD Biotech

Delighted Dr Marie Roskrow is the new Chair @PBDBiotech to support development of our rapid TB diagnostic. A physician-scientist she brings expertise from @KinomicaLtd @ImevaX along with Patrys Limited, METALINEAR LIMITED, ArcticZymes Technologies

Read More
PBD Biotech

Testing 4 tuberculosis gained renewed attention in 2022 reports @360DxNews Highlighting $30m funding @UNITAID for @FINDdx also @PBDBiotech gaining $2.9M for its blood-based test to predict which individuals with latent TB will progress to active disease

Read More